We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Neurology

Neurology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Neurotransmitter-Guided Connectome Disruption as a Key to Poststroke Language Impairment
NeurologyConnectomicsstroke

Neurotransmitter-Guided Connectome Disruption as a Key to Poststroke Language Impairment

By MedXY|Aug 15, 2026

Damage to serotonergic and dopaminergic neurotransmitter-linked networks predicts variability in acute and chronic poststroke language impairment, offering new insights beyond traditional lesion metrics.

DWI-Positive Lesions in Acute Intracerebral Hemorrhage: Insights into Cerebral Small Vessel Disease and Prognosis
Neurologyfunctional outcomeDiffusion-weighted imaging

DWI-Positive Lesions in Acute Intracerebral Hemorrhage: Insights into Cerebral Small Vessel Disease and Prognosis

By MedXY|Aug 15, 2026

DWI-positive lesions in acute intracerebral hemorrhage patients correlate with cerebral small vessel disease markers and predict poorer 6-month outcomes, with lesion distribution varying by small vessel disease subtype.

Plasma Biomarkers for Neocortical Tau Burden
Neurologyタウ病理Plasma Proteins

Plasma Biomarkers for Neocortical Tau Burden

By MedXY|Aug 15, 2026

A multiprotein plasma panel improves detection of advanced neocortical tau pathology in Alzheimer’s disease risk individuals beyond p-tau217 alone, enhancing patient stratification and clinical trial selection.

Unraveling Lesion Progression in Adult Cerebral Adrenoleukodystrophy to Inform Personalized Management
NeurologyMRIlesion progression

Unraveling Lesion Progression in Adult Cerebral Adrenoleukodystrophy to Inform Personalized Management

By MedXY|Aug 14, 2026

This multicenter study characterizes lesion growth variability in adult cerebral adrenoleukodystrophy, highlighting key MRI and biomarker predictors to guide personalized treatment and improve clinical trial designs.

Inebilizumab Significantly Reduces Exacerbations and Need for Rescue Therapy in Generalized Myasthenia Gravis: Insights from the Phase 3 MINT Trial
Allergy & Immunologyinebilizumabexacerbations

Inebilizumab Significantly Reduces Exacerbations and Need for Rescue Therapy in Generalized Myasthenia Gravis: Insights from the Phase 3 MINT Trial

By MedXY|Aug 14, 2026

The MINT trial demonstrates that inebilizumab markedly lowers exacerbation rates and rescue therapy use in AChR+ and MuSK+ generalized myasthenia gravis patients undergoing corticosteroid tapering.

Balancing Risks: Antiplatelet Therapy After Intracerebral Haemorrhage in the STATICH Trial
Internal Medicinestroke preventionAntiplatelet Therapy

Balancing Risks: Antiplatelet Therapy After Intracerebral Haemorrhage in the STATICH Trial

By MedXY|Aug 18, 2026

The STATICH trial assessed safety and efficacy of antiplatelet therapy after intracerebral hemorrhage, revealing increased hemorrhagic risk but fewer ischemic events among treated patients, highlighting ongoing clinical dilemmas.

Reevaluating Age as a Prognostic Marker in Molecularly Defined Lower-Grade Gliomas
Neurologyagelower-grade glioma

Reevaluating Age as a Prognostic Marker in Molecularly Defined Lower-Grade Gliomas

By MedXY|Aug 13, 2026

This article examines how age, traditionally considered a high-risk factor in lower-grade gliomas, influences prognosis and treatment decisions in the molecular era, highlighting the importance of IDH mutation status.

Oral Anticoagulants, Cognition, and Clinical Outcomes in Atrial Fibrillation and Alzheimer’s Disease: Insights from a Swedish Nationwide Study
CardiologyNOACsoral anticoagulants

Oral Anticoagulants, Cognition, and Clinical Outcomes in Atrial Fibrillation and Alzheimer’s Disease: Insights from a Swedish Nationwide Study

By MedXY|Aug 13, 2026

This review synthesizes evidence linking NOAC use to slower cognitive decline and improved clinical outcomes in patients with atrial fibrillation and Alzheimer’s disease, highlighting advantages over warfarin and non-use.

Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study
NeurologyAntibody TestingCell-Based Assays

Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study

By MedXY|Aug 13, 2026

The ADAM Study demonstrates superior diagnostic accuracy of live cell-based assays over fixed cell-based and ELISA tests for detecting AChR antibodies in myasthenia gravis, highlighting important clinical implications for antibody testing s

Unraveling the Neurobiological Pathways Linking Childhood Trauma to Bipolar Disorder: Insights from the ENIGMA Consortium
Neurologybrain morphologycortical thickness

Unraveling the Neurobiological Pathways Linking Childhood Trauma to Bipolar Disorder: Insights from the ENIGMA Consortium

By MedXY|Aug 12, 2026

An international study reveals that childhood trauma’s association with bipolar disorder is partially mediated by brain morphology changes, particularly in hippocampal volume and frontal cortical thickness.

Deep Learning-Driven Synthetic MR Perfusion Maps: A Breakthrough in Acute Ischemic Stroke Imaging
NeurologyMRIsynthetic perfusion maps

Deep Learning-Driven Synthetic MR Perfusion Maps: A Breakthrough in Acute Ischemic Stroke Imaging

By MedXY|Aug 12, 2026

This study presents a deep learning model that generates synthetic T-max perfusion maps from noncontrast DWI and FLAIR sequences, potentially streamlining stroke imaging and eliminating the need for contrast agents.

Advancing Myasthenia Gravis Diagnosis: The Superior Accuracy of Cell-Based Assays in Antibody Detection
NeurologyAntibody TestingCell-Based Assay

Advancing Myasthenia Gravis Diagnosis: The Superior Accuracy of Cell-Based Assays in Antibody Detection

By MedXY|Aug 12, 2026

The ADAM study reveals that live and fixed cell-based assays outperform ELISA in detecting AChR and MuSK antibodies, offering enhanced diagnostic accuracy for myasthenia gravis, particularly in ocular cases.

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders
Neurologypathologygenetics

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders

By MedXY|Aug 12, 2026

This study analyzes clinicopathological and genetic correlations in Parkinsonian disorders across diverse ancestries, revealing diagnostic challenges, genetic influences, and ancestry-related pathological variations.

Brain Structure Changes in Chronic Cough: Insights from a Large-Scale Longitudinal Study
NeurologyneuroplasticityBrain Atrophy

Brain Structure Changes in Chronic Cough: Insights from a Large-Scale Longitudinal Study

By MedXY|Aug 11, 2026

This large-scale longitudinal study reveals that chronic cough is linked with widespread grey matter volume reductions and accelerated brain atrophy, highlighting potential neurostructural underpinnings of cough hypersensitivity.

Enhancing Stroke Recovery: Adjunctive Normobaric Hyperoxia with Endovascular Thrombectomy in Late-Presenting Large Vessel Occlusion
NeurologyNeurological recoveryNormobaric hyperoxia

Enhancing Stroke Recovery: Adjunctive Normobaric Hyperoxia with Endovascular Thrombectomy in Late-Presenting Large Vessel Occlusion

By MedXY|Aug 11, 2026

A phase IIb trial shows that adding normobaric hyperoxia to endovascular thrombectomy in acute ischemic stroke patients 6 to 24 hours after onset is safe, improves early neurological outcomes, and reduces infarct volume, warranting larger c

Brain-Predicted Age Difference Enhances Dementia Risk Stratification in Subjective Cognitive Decline Beyond Standard MRI Assessment
NeurologyMRIBrain Age

Brain-Predicted Age Difference Enhances Dementia Risk Stratification in Subjective Cognitive Decline Beyond Standard MRI Assessment

By MedXY|Aug 11, 2026

Brain-predicted age difference (brain-PAD) from MRI improves early dementia risk prediction in patients with subjective cognitive decline, outperforming traditional visual MRI ratings and offering prognostic value beyond amyloid biomarkers,

Tailoring Blood Pressure Targets After Endovascular Therapy in Acute Ischemic Stroke: Clinical Trial Insights
Cardiologypersonalized medicineEndovascular therapy

Tailoring Blood Pressure Targets After Endovascular Therapy in Acute Ischemic Stroke: Clinical Trial Insights

By MedXY|Aug 11, 2026

A randomized trial shows reperfusion-guided blood pressure management post-thrombectomy improves functional outcomes and reduces hemorrhagic transformation, supporting personalized BP targets based on reperfusion status.

Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial
Neurologytranscranial magnetic stimulationdepression

Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial

By MedXY|Aug 10, 2026

This randomized trial compared connectivity-based versus scalp-based targeting of accelerated TMS in treatment-resistant depression, showing greater antidepressant effects with individualized connectivity-guided targeting.

Deciphering the Link Between Postoperative Delirium, Rehospitalization, and Cognitive Decline in Older Adults
Internal Medicinerehospitalizationpostoperative delirium

Deciphering the Link Between Postoperative Delirium, Rehospitalization, and Cognitive Decline in Older Adults

By MedXY|Aug 10, 2026

This study investigates whether recurrent hospitalizations mediate the association of postoperative delirium with long-term cognitive decline in seniors after major surgery, finding that rehospitalization does not significantly affect this

Evaluating Low-Dose Colchicine for Preventing Vascular Events After Acute Intracerebral Hemorrhage: Insights from a Placebo-Controlled Pilot Trial
Cardiologyvascular events preventionrandomized clinical trial

Evaluating Low-Dose Colchicine for Preventing Vascular Events After Acute Intracerebral Hemorrhage: Insights from a Placebo-Controlled Pilot Trial

By MedXY|Aug 9, 2026

This pilot randomized trial demonstrates the feasibility of using low-dose colchicine after acute intracerebral hemorrhage to prevent vascular events, highlighting considerations for future larger studies regarding recruitment, adherence, a

Prev
6 / 25
1…45678…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles